FATE   $3.15  0.0 Market Open

Fate Therapeutics Inc
Total Cash 304.88M
totalCashPerShare 2.677
EBITDA -163.44M
Total Debt 100.56M
quickRatio 8.842
currentRatio 9.18
Total Revenue 12.32M
debtToEquity 25.332
Revenue/Share 0.119
ROA -0.20497999
ROE -0.42103
grossProfits
freeCashflow -66.67M
operatingCashflow -140.57M
earningsGrowth
revenueGrowth 6.258
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -6.65727
profitMargins 0.0
enterpriseValue 163.51M
forwardPE -1.9226191
floatShares 90.27M
sharesOutstanding 113.88M
sharesShort 14.18M
sharesShortPriorMonth 15.17M
dateShortInterest
sharesPercentSharesOut 0.12%
heldPercentInsiders 0.02%
heldPercentInstitutions 1.08%
Short Ratio help_outline 13.95%
shortPercentOfFloat 0.14%
impliedSharesOutstanding
bookValue 3.487
Price To Book help_outline 0.93
earningsQuarterlyGrowth
netIncomeToCommon -175.72M
trailingEps -1.70%
forwardEps -1.68%
enterpriseToEbitda -1.00
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.43 3Q 2024
institutionsCount 240
lastUpdated Oct. 21, 2024, 1:27 p.m.